Vorobyev, Vladimir
Inserm · National and Kapodistrian University of Athens · Université de Lille · Centre Hospitalier Universitaire de Lille · Sorbonne Université · Hôpital Saint-Antoine · Istanbul University
3 papers on CoChatORCID 0000-0002-2692-8961
Most cited papers
- Verified
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Facon, T., Dimopoulos, M.-A., Leleu, X. P., Beksac, M., Pour, L., Hájek, R., Liu, Z., Minarik, J., Moreau, P., Romejko-Jarosinska, J., et al. (2024) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 284
- Verified
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
Dimopoulos, M. A., Beksac, M., Pour, L., Delimpasi, S., Vorobyev, V., Quach, H., Spicka, I., Radocha, J., Robak, P., Kim, K., et al. (2024) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors
Cited by 189
- Verified
Efficacy and safety of the randomized, open-label, non-inferiority, phase 3 study of subcutaneous (SC) versus intravenous (IV) daratumumab (DARA) administration in patients (pts) with relapsed or refractory multiple myeloma (RRMM): COLUMBA.
Mateos, M.-V., Nahi, H., Legiec, W., Grosicki, S., Vorobyev, V., Spicka, I., Hungria, V. T., Korenkova, S., Bahlis, N. J., Flogegard, M., et al. (2019) · Journal of Clinical Oncology
Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free